A randomized placebo-controlled one-center trial will be used to compare the efficacy of 26-week intervention , composed of either 1320mg/day of EPA and 880mg/day of DHA , or olive oil placebo with regard to symptom severity and relapse rate in first-episode schizophrenia patients .